Yang, Yaping
Wang, Ying
Deng, Heran
Tan, Cui
Li, Qian
He, Zhanghai
Wei, Wei
Zhou, Enxiang
Liu, Qiang
Liu, Jieqiong http://orcid.org/0000-0001-7859-3764
Funding for this research was provided by:
National Natural Science Foundation of China (81602673)
Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology ([2013]163)
Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes (KLB09001)
Article History
Received: 25 April 2018
Accepted: 10 May 2019
First Online: 6 June 2019
Ethics approval and consent to participate
: Ethical approval was obtained from participating institutions through their respective institutional review boards (IRB) (Sun Yat-sen Memorial Hospital Ethics Committee and IRB, Ethics Committee and IRB of Peking University Shenzhen Hospital, and Ethics Committee and IRB of the Second Xiangya Hospital, Central South University), and written informed consent was obtained from study participants.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.